These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37187754)

  • 1. Improvement of cognitive function in wild-type and Alzheimer´s disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells.
    Casares N; Alfaro M; Cuadrado-Tejedor M; Lasarte-Cia A; Navarro F; Vivas I; Espelosin M; Cartas-Cejudo P; Fernández-Irigoyen J; Santamaría E; García-Osta A; Lasarte JJ
    Front Immunol; 2023; 14():1130044. PubMed ID: 37187754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccination in early Alzheimer's disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells.
    Yang Y; He Z; Xing Z; Zuo Z; Yuan L; Wu Y; Jiang M; Qi F; Yao Z
    J Neuroinflammation; 2020 Feb; 17(1):65. PubMed ID: 32075657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice.
    Lasarte-Cia A; Lozano T; Pérez-González M; Gorraiz M; Iribarren K; Hervás-Stubbs S; Sarobe P; Rabal O; Cuadrado-Tejedor M; García-Osta A; Casares N; Lasarte JJ
    Front Immunol; 2018; 9():68. PubMed ID: 29422905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of TIPE2, a Negative Regulator of Innate and Adaptive Immunity, Attenuates Cognitive Deficits in APP/PS1 Mice.
    Miao Y; Wang N; Shao W; Xu Z; Yang Z; Wang L; Ju C; Zhang R; Zhang F
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):519-529. PubMed ID: 31286344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic impacts on brain pathology, anxiety, and cognitive function in the knock-in APP
    Mehla J; Deibel SH; Karem H; Hossain S; Lacoursiere SG; Sutherland RJ; Mohajerani MH; McDonald RJ
    Alzheimers Res Ther; 2022 Sep; 14(1):143. PubMed ID: 36180883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine immunomodulation network dysfunction in SAMP8 mice and PrP-hAβPPswe/PS1ΔE9 mice: potential mechanism underlying cognitive impairment.
    Wang JH; Cheng XR; Zhang XR; Wang TX; Xu WJ; Li F; Liu F; Cheng JP; Bo XC; Wang SQ; Zhou WX; Zhang YX
    Oncotarget; 2016 Apr; 7(17):22988-3005. PubMed ID: 27049828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the App
    Arroyo-García LE; Isla AG; Andrade-Talavera Y; Balleza-Tapia H; Loera-Valencia R; Alvarez-Jimenez L; Pizzirusso G; Tambaro S; Nilsson P; Fisahn A
    Mol Psychiatry; 2021 Oct; 26(10):5557-5567. PubMed ID: 34385602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in open field activity in the absence of memory deficits in the App
    Whyte LS; Hemsley KM; Lau AA; Hassiotis S; Saito T; Saido TC; Hopwood JJ; Sargeant TJ
    Behav Brain Res; 2018 Jan; 336():177-181. PubMed ID: 28887197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model.
    Park TS; Ryu YK; Park HY; Kim JY; Go J; Noh JR; Kim YH; Hwang JH; Choi DH; Oh WK; Lee CH; Kim KS
    Int J Mol Med; 2017 Jan; 39(1):21-30. PubMed ID: 28004107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoted CD4
    Wu X; Shen Q; Chang H; Li J; Xing D
    J Neuroinflammation; 2022 Oct; 19(1):253. PubMed ID: 36217178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APP
    Mehla J; Lacoursiere SG; Lapointe V; McNaughton BL; Sutherland RJ; McDonald RJ; Mohajerani MH
    Neurobiol Aging; 2019 Mar; 75():25-37. PubMed ID: 30508733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice.
    Zhang S; Wei D; Lv S; Wang L; An H; Shao W; Wang Y; Huang Y; Peng D; Zhang Z
    J Alzheimers Dis; 2022; 89(3):955-975. PubMed ID: 35964195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal progression of Alzheimer's disease in brains and intestines of transgenic mice.
    Manocha GD; Floden AM; Miller NM; Smith AJ; Nagamoto-Combs K; Saito T; Saido TC; Combs CK
    Neurobiol Aging; 2019 Sep; 81():166-176. PubMed ID: 31284126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ effector T cells accelerate Alzheimer's disease in mice.
    Machhi J; Yeapuri P; Lu Y; Foster E; Chikhale R; Herskovitz J; Namminga KL; Olson KE; Abdelmoaty MM; Gao J; Quadros RM; Kiyota T; Jingjing L; Kevadiya BD; Wang X; Liu Y; Poluektova LY; Gurumurthy CB; Mosley RL; Gendelman HE
    J Neuroinflammation; 2021 Nov; 18(1):272. PubMed ID: 34798897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 Suppresses Oxidative Stress and Inflammation in
    Uruno A; Matsumaru D; Ryoke R; Saito R; Kadoguchi S; Saigusa D; Saito T; Saido TC; Kawashima R; Yamamoto M
    Mol Cell Biol; 2020 Feb; 40(6):. PubMed ID: 31932477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.